Body distributioin of RGD-mediated liposome in brain-targeting drug delivery

Yakugaku Zasshi

Volumn 127, Issue 9, 2007, Pages 1497-1501

  Qin, Jing ^a   Chen, DaWei ^a   Hu, HaiYang ^a   Qiao, MingXi ^a   Zhao, XiuLi ^a   Chen, BaoYu ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Body distribution; Brain targeting; Ferulic acid; Flow cytometric

Indexed keywords

FERULIC ACID; INTERLEUKIN 1BETA; LIPOSOME; SALICYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; ENCEPHALITIS; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MICROINJECTION; NONHUMAN; RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELLS, CULTURED; COUMARIC ACIDS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; HUMANS; LIPOSOMES; MALE; MONOCYTES; NEUTROPHILS; OLIGOPEPTIDES; RATS; RATS, WISTAR; SUCCINIC ANHYDRIDES; TISSUE DISTRIBUTION;

EID: 34548456395     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.127.1497     Document Type: Article

References (19)

1. Brightman M. W., Reese T. S., J. Cell Biol., 40, 649-677 (1969).
2. Reese T. S., Karnovsky M. J., J. Cell Biol. 34, 207-217 (1967).
3. Perry V. H., Mike D. B., Heidi C. B., Malgosia K. M., Curr. Opin. Neurobiol., 5, 636-641 (1995).
4. Perry V. H., Anthony D. C., Bolton S. J., Brown H. C., Mole. Medi. Today, 8, 335-341 (1997).
5. Chopp W. M., Zhang R. L., Chen H., Li Y., Jiang N., Rusche J. R., Stroke, 25, 869-875 (1994).
6. Clark W. M., Madden K. P., Rothlein R., Zivin J. A., J. Neurosurg., 75, 623-627 (1994).
7. Gendeiman H. E., Lipton S. A., Tardieu M., Bukrinsky M. I., Nottet H. S. L. M., J. Leukocyte Biol., 56, 389-398 (1994).
8. Jain S., Mishra V., Singh P., Dubey P. K., Saraf D. K., Vyasa S. P., Int. J. Pharm., 261, 43-55 (2003).
9. Saiki I., Koike C., Obata A., Fuji H., Murata J., Kiso M., Hasegawa A., Komazawa H., Int. J. Cancer, 65, 833-839 (1996).
10. Richard G. L., Ruben V. H., James E. O., Joe L. M. J., Neurosci. Lett., 339, 199-202 (2003).
11. Hauzenberger D., Klominek J., Sundqvist K. G., J. Immunol., 153, 960-971 (1993).
12. Gururaj J., Marzia P., Rukhsana S., Ravagna A., Vittorio C., Butterfield D. A., Neurochem. Int., 48, 318-327 (2006).
13. Kanski J., Aksenova M., Stoyanova A., Butterfield D. A., J. Nutr. Biochem., 13, 273-281 (2002).
14. Kim H. S., Cho J. Y., Kim D. H., Yan J. J., Lee H. K., Suh H. W., Song D. K., Biol. Pharm. Bull., 27, 120-121 (2004).
15. Srinivasan M., Ram S. A., Raveendran P. K., Kumarc P. R., Sudhakaran P. R., Menon V. P., Toxicology, (2006) (in press).
16. Ogiwara T., Satoh K., Kadoma Y., Murakami Y., Unten S., Atsumi T., Sakagami H., Fujisawa S., Anticancer Res., 22, 2711-2717 (2002).
17. Anthoy D. C., Bolton S. J., Fearn S. J., Fearn S., Perry V. H., Brain, 120, 435-444 (1997).
18. Wen A. D., Jiang Y. P., Huang X., Fan Y. X., Zhang L. H., J.Chin. Pharm. Sci., 4, 199-204 (1995).
19. Senior R. M., Gresham H. D., Grin G. L., Brown E. J., Chung A. E., J. Clin. Invest., 90, 2251-2257 (1992).